Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation | Zendy

Anne Sig Vestergaard | Zendy; Flemming Skjøth | Zendy; Gregory Y.H. Lip | Zendy; Torben Bjerregaard Larsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation

Author(s) -

Anne Sig Vestergaard,

Flemming Skjøth,

Gregory Y.H. Lip,

Torben Bjerregaard Larsen

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.012338

Subject(s) - medicine , atrial fibrillation , warfarin , confidence interval , stroke (engine) , adverse effect , retrospective cohort study , emergency medicine , pediatrics , surgery , mechanical engineering , engineering

Intracranial hemorrhage (ICH) is the most feared adverse event with oral anticoagulant therapy in patients with atrial fibrillation. The health economic aspects of resuming oral anticoagulant therapy after ICH are unknown. The aim was to estimate hospitalization costs of thromboembolism and hemorrhage subsequent to ICH in 2 patient groups with atrial fibrillation surviving the first 90 days post ICH: (1) patients resuming warfarin therapy within 90 days post ICH and (2) patients discontinuing therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research